Royalty Pharma (RPRX) Interest Coverage Ratio (2019 - 2026)

Royalty Pharma has disclosed Interest Coverage Ratio across 8 years of filings, most recently posting 6.01 for Q1 2026.

• Interest Coverage Ratio for Q1 2026 came in at 6.01, down 26.61% year-over-year; the trailing twelve-month figure through Mar 2026 was 4.73 (down 38.69% YoY), and the FY2025 annual result was 5.07, down 11.56% from the prior year.
• Interest Coverage Ratio came in at 6.01 for Q1 2026 at Royalty Pharma, up from 4.12 in the prior quarter.
• In the past five years, Interest Coverage Ratio ranged from a high of 12.97 in Q4 2023 to a low of 10.28 in Q4 2022.
• The 5-year median for Interest Coverage Ratio is 5.37 (2025), against an average of 5.02.
• Across the five-year window, Interest Coverage Ratio tumbled 414.73% in 2022 and soared 590.76% in 2025, its largest moves.
• Royalty Pharma's Interest Coverage Ratio stood at 10.28 in 2022, then surged by 226.18% to 12.97 in 2023, then slumped by 57.61% to 5.5 in 2024, then declined by 24.98% to 4.12 in 2025, then surged by 45.66% to 6.01 in 2026.
• The last three Interest Coverage Ratio figures came in at 6.01 (Q1 2026), 4.12 (Q4 2025), and 5.37 (Q3 2025), per Business Quant data.